The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Cell & Gene
    • Bioprocessing
    • Drug Delivery
    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Regulation & Standards
    • Small Molecules
    • Supply Chain
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • eBooks
    • Content Hubs
Subscribe
Subscribe
The Medicine Maker / Issues / 2026 / June / How Zealand Pharma Is Scaling Quality Without Complexity
Bioprocessing Interviews Technology & Manufacturing Digital Technologies Quality & Compliance Regulation & Standards Standards & Regulation Sponsored

How Zealand Pharma Is Scaling Quality Without Complexity

How connected quality systems can help growing biotechs remain agile.

06/29/2026 0 min read Video

Share

As biotech companies grow, so does the complexity of their quality processes. How can teams expand without creating disconnected systems, duplicated work, and barriers for users?

Kamilla Vagtborg, Director and Head of Quality Systems at Zealand Pharma, explains how bringing documents, training, quality processes, and validation into one ecosystem can improve transparency and make information easier to navigate. She also discusses the value of investing in the right infrastructure early while keeping systems simple and adaptable as the organization evolves.

Watch the interview.

Newsletters

Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Recommended

Related Content

Musings From the Power List: Jason Bock
Development & Clinical Cell & Gene Interviews
Musings From the Power List: Jason Bock

October 14, 2026

12 min read

Jason Bock shares his outlook on RNA-targeting therapies, personalized medicine, and the future of drug development

Find the Achilles’ Heel: Sitting Down With Amy Jensen-Smith
Development & Clinical Biopharma Interviews
Find the Achilles’ Heel: Sitting Down With Amy Jensen-Smith

October 12, 2026

8 min read

SOTIO Biotech’s CSO explains why drug developers should test their weakest assumptions early, how she builds innovative teams, and where ADCs could go next

Musings from The Power List: Andres Sirulnik
Development & Clinical Biopharma Interviews
Musings from The Power List: Andres Sirulnik

October 5, 2026

4 min read

Regeneron's L. Andres Sirulnik explains why modernizing clinical trials is as important as developing new medicines

Musings from The Power List: Fabian Gerlinghaus
Development & Clinical Cell & Gene Interviews
Musings from The Power List: Fabian Gerlinghaus

October 1, 2026

3 min read

Cellares Co-Founder and CEO discusses why the future of cell therapy depends on rethinking how therapies are made

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Your Privacy Choices
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions: